Navigation Links
Seventeen Months After Cord Blood Transplant - Child is Free of Signs of Cancer
Date:1/9/2009

National Cord Blood Program Provides Stem Cells

NEW YORK, Jan. 9 /PRNewswire-USNewswire/ -- A two year old child from Florida is free of signs of juvenile myelomonocytic leukemia (JMML), a very rare form of pediatric leukemia, seventeen months after receiving a transplant with cord blood from the National Cord Blood Program (NCBP) of the New York Blood Center's Howard P. Milstein National Cord Blood Center.

Juvenile myelomonocytic leukemia generally affects children under the age of five and comprises less than one percent of infant leukemias. The prognosis for JMML is generally poor and most children with JMML die before reaching the age of three.

Adolfo Gonzalez was diagnosed with JMML when he was thirteen months old. "Adolfo Gonzalez would most likely not be alive today if it weren't for the cord blood transplant," said Gary Kleiner, M.D., Ph.D., pediatric immunologist at the University of Miami School of Medicine. "The mother who donated her cord blood to the public cord blood bank at New York's National Cord Blood Program basically saved his life."

Adolfo's treatment included chemotherapy to destroy his leukemia cells followed by a cord blood stem cell transplant from NCBP. He did endure some complications, but approximately two weeks after he had received the infusion of the stem cells, his white cell count began to return to normal. Adolfo has no signs of any leukemia seventeen months later.

"We're thrilled that NCBP, the first and largest public cord blood bank in the world, was able to help Adolfo and his family," said NCBP Chief Scientist Pablo Rubinstein, M.D. "He's among almost 3,000 people who have received a match from the 50,000 units we've frozen since 1992."

Note: WCTV in Tallahassee, Florida conducted an in-depth interview with Dr. Kleiner. A full transcript, along with Dr. Kleiner's media contact information, is available at this link:

http://www.wctv.tv/medicalminute/interviewheadlines/36761699.html

About National Cord Blood Program (NCBP)

Launched in 1992, NCBP was the first established cord blood bank to collect, process, test and store cord blood units and make them available for transplantation for any patient in need for a hematopoietic stem cell transplant. NCBP accepts requests from all over the world. Cord blood units can be accessed through the NETCord database, and now through the Single Point of Access (SPA) of the National Marrow Donor Program.

About New York Blood Center (NYBC)

New York Blood Center (NYBC) is one of the nation's largest non-profit, community-based blood centers. NYBC has been providing blood, transfusion products and services to patients in greater New York since 1964. NYBC is also home to the Lindsley F. Kimball Research Institute and the National Cord Blood Program at the Howard P. Milstein National Cord Blood Center, the world's largest public cord blood bank. NYBC provides medical services and programs (Clinical, Transfusion, and Hemophilia Services) through our medical professionals and transfusion medicine physicians.

    Contact: Christine Dingfelder
    (212) 570-3227 Office / (917) 763-1648 Cell



'/>"/>
SOURCE New York Blood Center
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CCA Industries, Inc. Declares Its Seventeenth Consecutive Dividend
2. Lee County School District online wellness program inspires employees to walk 200 million steps in 2 months
3. Mammogram most effective 12 months after radiation treatment
4. Amilpar Revenues Grow 28% in the First 9 Months of 2008 and 4.5% Over Previous Quarter
5. Miami Clinic Owner Sentenced to 30 Months in Prison for $10.9 Million Medicare Fraud
6. Lees Pharmaceutical Kept Up the Rapid Pace of Growth; Profit Attributable to Shareholders Surged 176% in the Nine Months of 2008
7. International Isotopes Inc. Announces Third Quarter and Nine Months 2008 Financial Results
8. Mindray Announces 2008 Third Quarter and Nine Months Results
9. Miami Physician Sentenced to 84 Months in Prison for $26.2 Million Medicare Fraud
10. Trubion Pharmaceuticals Provides Announcement Dates for Third-Quarter and Nine Months Earnings Conference Call
11. Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... 2017 , ... SignatureCare Emergency Center is looking to award their ... to a deserving student. Get your applications in now as the deadline is ... Castillo who is a nursing student at Prairie View A&M University with a 3.45 ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... Oakland, California effectively destroyed the construction site and threatened numerous homes and businesses ... 7th article on NBCLosAngeles.com. Los Angeles Area consulting firm Fire Protection ...
(Date:7/24/2017)... CLARA, CA (PRWEB) , ... July 24, 2017 , ... ... and financial organizations, today announced it has partnered with WALLIX to expand ... Special Publication 800-171 . , There are a number of ways to address the ...
(Date:7/24/2017)... California (PRWEB) , ... July 24, 2017 , ... ... of autologous fat (adipose) transfer systems announces the issuance of United States Patent ... patent) for its adipose filtration technology. The '398 and '324 patents cover ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... sleep management solution focused on delivering end-to-end sleep health care at scale, ... Recent literature shows that adherence rates for positive airway pressure (PAP) therapy, the ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... and EDMONTON, Alberta , July ... and the University of Alberta in ... in Nature,s partner journal, Schizophrenia 1 , demonstrating ... instances of schizophrenia with 74% accuracy. This retrospective ... of specific symptoms in schizophrenia patients with significant ...
(Date:7/21/2017)... , July 21, 2017  Endo International plc (NASDAQ: ... a comprehensive review of its manufacturing network, the Company ... distribution facilities in Huntsville, Alabama . ... place over the next 12 to 18 months. The ... by declining volumes of commoditized products and these restructuring ...
(Date:7/20/2017)... , July 20, 2017  Prime Therapeutics LLC (Prime) ... Gavras , M.D., following today,s Institute for Clinical and Economic ... on the effectiveness and value of abuse-deterrent formulations (ADF) ... the policy roundtable at the meeting. ... a material cost benefit to the use of abuse-deterrent formulations ...
Breaking Medicine Technology: